News Summary: K-V Pharma files Chapter 11
16:36 EDT 6 Aug 2012 | Advantage Business Media
CHAPTER 11: K-V Pharmaceutical Co. filed for Chapter 11 bankruptcy protection Saturday, saying weak sales of its preterm birth drug Makena and regulatory sanctions are hurting its business.REORGANIZING: The St. Louis company plans to stay in business..
Original Article: News Summary: K-V Pharma files Chapter 11
More From BioPortfolio on "News Summary: K-V Pharma files Chapter 11"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
